English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Amanda Rupp
| Jun 1, 2016
NCHC applauds hospital readmissions policy changes
Vimbai Chikomo
| Jun 1, 2016
HHS 'knowingly circumvented Congress and undermined the Constitution,' Basic Health Program probe reveals
Amanda Rupp
| Jun 1, 2016
CHMP gives positive opinion of Zepatier tablet
Amanda Rupp
| Jun 1, 2016
FDA approves Zinbryta to treat MS
Kim Sunderland
| Jun 1, 2016
Independent Women’s Forum policy expert says more diverse health insurance plans are needed across U.S.
Amanda Rupp
| Jun 1, 2016
FDA approves new diagnostic imaging agent for recurrent prostate cancer
Amanda Rupp
| Jun 1, 2016
Bristol-Myers Squibb responds to ICER report
Amanda Rupp
| Jun 1, 2016
First buprenorphine implant treatment for opioid dependence earns FDA approval
Trending
Patient Daily
| Sep 3, 2025
Top healthcare marketing experts to present at AOCOO-HNS 2025 virtual mid-year symposium, led by Greg Caesar of Medfluence Advisors
+
Pharmaceuticals
Patient Daily
| Sep 4, 2025
PhRMA CEO on 340B abuse: ‘Big hospitals are abusing the 340B program to markup medicine prices’
+
Pharmaceuticals
Patient Daily
| Sep 2, 2025
Fmr. Gov. Dean on 340B: ‘There's no actual requirement for hospitals to pass along the savings’
+
Pharmaceuticals
Patient Daily
| Aug 29, 2025
Deputy VP of Public Affairs of PhRMA on 340B: ‘Over 80% of all rural hospital beds were actually in urban hospitals’
« First
«
…
219
220
221
222
223
224
225
…
»
Last »